Patent details
EP3889172 Title: TARGETED TGF BETA INHIBITION
Basic Information
- Publication number:
- EP3889172
- PCT Application Number:
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP211657093
- PCT Publication Number:
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- TARGETED TGF BETA INHIBITION
- French Title of Invention:
- INHIBITION CIBLEE DE FACTEUR DE CROISSANCE DE TRANSFORMATION BÊTA (TGFBETA)
- German Title of Invention:
- GEZIELTE TGF-BETA-HEMMUNG
- SPC Number:
Dates
- Filing date:
- 10/02/2015
- Grant date:
- 01/05/2024
- EP Publication Date:
- 06/10/2021
- PCT Publication Date:
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 01/05/2024
- EP B1 Publication Date:
- 01/05/2024
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 10/02/2025
- Expiration date:
- 10/02/2035
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 24/04/2024
- Name:
- Merck Patent GmbH
- Address:
- Frankfurter Strasse 250, 64293 Darmstadt, Germany (DE)
Inventor
- Name:
- LO, Kin-Ming
- Address:
- United States (US)
Priority
- Priority Number:
- 201461938048 P
- Priority Date:
- 10/02/2014
- Priority Country:
- United States (US)
Classification
- IPC classification:
- C07K 14/71; C07K 16/22; C07K 16/28; C07K 16/46; C07K 19/00;
Publication
European Patent Bulletin
- Issue number:
- 202418
- Publication date:
- 01/05/2024
- Description:
- Grant (B1)
Annual Fees
- Annual Fee Due Date:
- Annual Fee Number:
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|